Back to search

Article

A new vulnerability to BET inhibition due to enhanced autophagy in BRCA2 deficient pancreatic cancer

2023-05-31

Abstract excerpt

Pancreatic cancer is one of the deadliest diseases in human malignancies. Among total pancreatic cancer patients, ∼10% of patients are categorized as familial pancreatic cancer (FPC) patients, carrying germline mutations of the genes involved in DNA repair pathways ( e.g., BRCA2 ). Personalized medicine approaches tailored toward patients’ mutations would improve patients’ outcome. To identify novel vulnerabiliti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7c044067-5a4a-5490-a40e-6cd80b620e39
DOI
10.1101/2023.05.30.542934
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A new vulnerability to BET inhibition due to enhanced autophagy in BRCA2 deficient pancreatic cancerDOI 10.1101/2023.05.30.542934
Select a neighboring publication to make it the new centre.